Clinical deterioration in community acquired infections associated with lymphocyte upsurge in immunocompetent hosts

Scandinavian Journal of Infectious Diseases

Volumn 36, Issue 10, 2004, Pages 743-751

  Cheng, Vincent C C ^a   Wu, Alan K L ^b   Hung, Ivan F N ^a   Tang, Bone S F ^a   Lee, Rodney A ^a   Lau, Susanna K P ^a   Woo, Patrick C Y ^a   Yuen, Kwok Yung ^a  

^a UNIVERSITY OF HONG KONG   (Hong Kong)

^b CHINESE UNIVERSITY OF HONG KONG   (Hong Kong)

Author keywords

[No Author keywords available]

Indexed keywords

ACICLOVIR; AMANTADINE; AMOXICILLIN PLUS CLAVULANIC ACID; ANTIBIOTIC AGENT; ANTIINFECTIVE AGENT; BRONCHODILATING AGENT; CEFOTAXIME; CHLORAMPHENICOL; DOXYCYCLINE; FAMCICLOVIR; LEVOFLOXACIN; METHYLPREDNISOLONE; MINOCYCLINE; PENICILLIN G; RIFAMPICIN; SULPERAZON; TUBERCULOSTATIC AGENT;

ADOLESCENT; ADULT; AGED; AIRWAY OBSTRUCTION; ARTICLE; BRUCELLOSIS; CAPILLARY LEAK SYNDROME; CENTRAL NERVOUS SYSTEM DISEASE; CHRONIC OBSTRUCTIVE LUNG DISEASE; CLINICAL ARTICLE; CLINICAL FEATURE; COHORT ANALYSIS; CONTROLLED STUDY; DENGUE; DISEASE COURSE; DISEASE EXACERBATION; DISEASE MARKER; FEMALE; HERPES ZOSTER; HOSPITALIZATION; HOST PATHOGEN INTERACTION; HUMAN; HUMAN CELL; IMMUNE DEFICIENCY; IMMUNE RESPONSE; IMMUNOPATHOLOGY; INTERSTITIAL PNEUMONIA; LEPTOSPIROSIS; LYMPHOCYTE COUNT; MALE; OUTCOMES RESEARCH; SCRUB TYPHUS; SIDE EFFECT; TISSUE INJURY; VIRUS ENCEPHALITIS; VIRUS PNEUMONIA;

EID: 7944222796     PISSN: 00365548     EISSN: None     Source Type: Journal    
DOI: 10.1080/00365540410022602     Document Type: Article

References (42)

1. Cheng VC, Yuen KY, Chan WM, Wong SS, Ma ES, Chan RM. Immunorestitution disease involving the innate and adaptive response. Clin Infect Dis 2000; 30: 882-92.
2. Cheng VC, Yuen KY, Wong SS, Woo PC, Ho PL, Lee R, Chan RM. Immunorestitution diseases in patients not infected with HIV. Eur J Clin Microbiol Infect Dis 2001; 20: 402-6.
3. Cheng VC, Hung IF, Wu AK, Tang BS, Chu CM, Yuen KY. Lymphocyte surge as a marker for immunorestitution disease due to Pneumocystis jiroveci pneumonia in HIV-negative immunosuppressed hosts. Eur J Clin Microbiol Infect Dis 2004; 23: 512-4.
4. Cheng VC, Ho PL, Lee RA, Chan KS, Chan KK, Woo PC, et al. Clinical spectrum of paradoxical deterioration during anti-tuberculosis therapy in non-HIV-infected patients. Eur J Clin Microbiol Infect Dis 2002; 21: 803-9.
5. Cheng VC, Yam WC, Woo PC, Lau SK, Hung IF, Wong SP, et al. Risk factors for development of paradoxical response during anti-tuberculosis therapy in HIV-negative patients. Eur J Clin Microbiol Infect Dis 2003; 22: 597-602.
6. Narita M, Ashkin D, Hollender ES, Pitchenik AE. Paradoxical worsening of tuberculosis following antiretroviral therapy in patients with AIDS. Am J Respir Crit Care Med 1998; 158: 157-61.
7. Wendel KA, Alwood KS, Gachuhi R, Chaisson RE, Bishai WR, Sterling TR. Paradoxical worsening of tuberculosis in HIV-infected persons. Chest 2001; 120: 193-7.
8. Orlovic D, Smego RA Jr. Paradoxical tuberculous reactions in HIV-infected patients. Int J Tuberc Lung Dis 2001; 5: 370-5.
9. Navas E, Martin-Davila P, Moreno L, Pintado V, Casado JL, Fortun J, et al. Paradoxical reactions of tuberculosis in patients with the acquired immunodeficiency syndrome who are treated with highly active antiretroviral therapy. Arch Intern Med 2002; 162: 97-9.
10. Cheng VC, Woo PC, Lau SK, Cheung CH, Yung RW, Yam LY, Yuen KY. Peripartum tuberculosis as a form of immunorestitution disease. Eur J Clin Microbiol Infect Dis 2003; 22: 313-7.
11. Valdez LM, Schwab P, Okhuysen PC, Rakita RM. Paradoxical subcutaneous tuberculous abscess. Clin Infect Dis 1997; 24: 734.
12. Sperber SJ, Schleupner CJ. Leptospirosis: a forgotten cause of aseptic meningitis and multisystem febrile illness. South Med J 1989; 82: 1285-8.
13. Hill MK, Sanders CV. Leptospiral pneumonia. Semin Respir Infect 1997; 12: 44-9.
14. Henchal EA, Putnak JR. The dengue viruses. Clin Microbiol Rev 1990; 3: 376-96.
15. Yuen KY, Seto WH, Chau PY. An evaluation of inpatient consultations conducted by clinical microbiologists in a teaching hospital. J Infection 1992; 25: 29-37.
16. Luk WK, Wong SS, Yuen KY, Ho PL, Woo PC, Lee R, et al. Inpatient emergencies encountered by an infectious disease consultative service. Clin Infect Dis 1998; 26: 695-701.
17. Blumberg RS, Schooley RT. Lymphocyte markers and infectious diseases. Semin Hematol 1985; 22: 81-114.
18. Jerrells TR. Immunosuppression associated with the development of chronic infections with Rickettsia tsutsugamushi: adherent suppressor cell activity and macrophage activation. Infect Immun 1985; 50: 175-82.
19. Kasuya S, Nagano I, Ikeda T, Goto C, Shimokawa K, Takahashi Y. Apoptosis of lymphocytes in mice induced by infection with Rickettsia tsutsugamushi. Infect Immun 1996; 64: 3937-41.
20. Jerrells TR, Osterman JV. Host defences in experimental scrub typhus: delayed-type hypersensitivity responses of inbred mice. Infect Immun 1982; 35: 117-23.
21. Jerrells TR, Osterman JV. Development of specific and cross-reactive lymphocyte proliferative responses during chronic immunizing infections with Rickettsia tsutsugamushi. Infect Immun 1983; 40: 147-56.
22. Palmer BA, Hetrick FM, Jerrells TJ. Production of gamma interferon in mice immune to Rickettsia tsutsugamushi. Infect Immun 1984; 43: 59-65.
23. Hickman CJ, Stover CK, Joseph SW, Oaks EV. Murine T-cell response to native and recombinant protein antigens of Rickettsia tsutsugamushi. Infect Immun 1993; 61: 1674-81.
24. Strickman D, Smith CD, Corcoran KD, Ngampochjana M, Watcharapichat P, Phulsuksombati D, et al. Pathology of Rickettsia tsutsugamushi infection in Bandicota savilei, a natural host in Thailand. Am J Trop Med Hyg 1994; 51: 416-23.
25. Park JS, Jee YK, Lee KY, Kim KY, Myong NH, Seo PW. Acute respiratory distress syndrome associated with scrub typhus: diffuse alveolar damage without pulmonary vasculitis. J Korean Med Sci 2000; 15: 343-5.
26. Rothman AL, Ennis FA. Immunopathogenesis of dengue haemorrhagic fever. Virology 1999; 257: 1-6.
27. Lei HY, Yeh TM, Liu HS, Lin YS, Chen SH, Liu CC. Immunopathogenesis of dengue virus infection. J Biomed Sci 2001; 8: 377-88.
28. Julkunen I, Melen K, Nyqvist M, Pirhonen J, Sareneva T, Matikainen S. Inflammatory responses in influenza A virus infection. Vaccine 2000; 19(Suppl 1): S32-7.
29. Varga SM, Braciale TJ. RSV-induced immunopathology: dynamic interplay between the virus and host immune response. Virology 2002; 295: 203-7.
30. Scherle PA, Palladino G, Gerhard W. Mice can recover from pulmonary influenza virus infection in the absence of class 1-restricted cytotoxic T-cells. J Immunol 1992; 148: 212-7.
31. Enelow RI, Mohammed AZ, Stoler MH, Liu AN, Young JS, Lou YH, Braciale TJ. Structural and functional consequences of alveolar cell recognition by CD8+ T-lymphocytes in experimental lung disease. J Clin Invest 1998; 102: 1653-61.
32. Graham BS, Bunton LA, Wright PF, Karzon DT. Role of T-lymphocyte subsets in the pathogenesis of primary infection and rechallenge with respiratory syncytial virus in mice. J Clin Invest 1991; 88: 1026-33.
33. Hodge G, Hodge S, Markus C, Lawrence A, Han P. A marked decrease in L-selectin expression by leucocytes in infants with Bordetella pertussis infection: leucocytosis explained? Respirology 2003; 8: 157-62.
34. Hudnall SD, Molina CP. Marked increase in L-selectin-negative T-cells in neonatal pertussis. The lymphocytosis explained? Am J Clin Pathol 2000; 114: 35-40.
35. Schenkel AR, Pauza CD. Pertussis toxin treatment in vivo reduces surface expression of the adhesion integrin leukocyte function antigen-1 (LFA-1). Cell Adhes Commun 1999; 7: 183-93.
36. Fumagalli LA, Vinke J, Hoff W, Ypma E, Brivio F, Nespoli A. Lymphocyte counts independently predict overall survival in advanced cancer patients: a biomarker for IL-2 immunotherapy. J Immunother 2003; 26: 394-402.
37. Fumagalli L, Lissoni P, Di Felice G, Meregalli S, Valsuani G, Mengo S, Rovelli F. Pretreatment serum markers and lymphocyte response to interleukin-2 therapy. Br J Cancer 1999; 80: 407-11.
38. Bosch JA, Berntson GG, Cacioppo JT, Dhabhar FS, Marucha PT. Acute stress evokes selective mobilization of T-cells that differ in chemokine receptor expression: a potential pathway linking immunologic reactivity to cardiovascular disease. Brain Behav Immun 2003; 17: 251-9.
39. Roe MF, Bloxham DM, White DK, Ross-Russell RI, Tasker RT, O'Donnell DR. Lymphocyte apoptosis in acute respiratory syncytial virus bronchiolitis. Clin Exp Immunol 2004; 137: 139-45.
40. Yuen KY, Chan PK, Peiris M, Tsang DN, Que TL, Shortridge KF, et al. Clinical features and rapid viral diagnosis of human disease associated with avian influenza A H5N1 virus. Lancet 1998; 351: 467-71.
41. Wong RS, Wu A, To KF, Lee N, Lam CW, Wong CK, et al. Haematological manifestations in patients with severe acute respiratory syndrome: retrospective analysis. Br Med J 2003; 326: 1358-62.
42. Hotchkiss RS, Tinsley KW, Swanson PE, Schmieg RE Jr, Hui JJ, Chang KC, et al. Sepsis-induced apoptosis causes progressive profound depletion of B- and CD4 + T-lymphocytes in humans. J Immunol 2001; 166: 6952-63.